How much funding has FZATA INC raised?

FZATA INC has raised $28.6M in total funding, most recently a Series A round.

Where is FZATA INC headquartered?

FZATA INC is headquartered in HALETHORPE, Maryland, United States.

FZATA INC

Gastrointestinal | Oral Yeast Biologics | Fzata, Inc.| Maryland

HALETHORPE, United States · Founded 2017 · $28.6M raised

Biotech

Headquarters: HALETHORPE, Maryland
Employees: 1–10
Founded: 2017
Business Model: B2B

Website: fzata.com
Total Funding: $28.6M
Last Round: $10.6M Series AMar 2026

About

Fzata, Inc. is a clinical-stage biopharmaceutical company based in Halethorpe, Maryland developing a first-in-class oral Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. The platform enables orally administered yeast micro-factories to produce biologic therapeutics on-site in the gut, targeting gastrointestinal disorders including C. difficile infection, inflammatory bowel disease, and metabolic diseases. Fzata's approach aims to replace injectable biologics with affordable, non-refrigerated oral capsules, improving patient access and quality of life.

Summary

FZATA INC is a Biotech company based in HALETHORPE, United States, founded in 2017. It has raised $28.6M in total, most recently a $10.6M Series A round in Mar 2026.